We have advised Intriva Capital, the independent alternative asset manager, on its acquisition of Sequence Care Group (Sequence), a leading provider of care homes and supported living services in London.
Intriva Capital is an alternative investment firm focused on sustainable value creation in mid-market businesses throughout Western Europe. The firm works alongside management teams to enhance the strategic, operational and financial trajectory of the assets it backs. It manages capital on behalf of leading institutional investors and has offices in the United Kingdom, Germany and Spain, and a diverse international team.
Founded in 2001 and working in close partnership with Local Authorities and the NHS, Sequence provides high-quality specialist care services which enable adults with complex learning difficulties to live richer, happier lives. The company employs more than 760 people, including experienced specialist teams comprised of occupational therapy, speech and language therapy, and positive behaviour support workers.
With Intriva’s support, Sequence will be able to expand its care services and footprint through developing new homes designed around the needs of individuals with learning disabilities and those with additional needs, such as a physical disability. Sequence will also look to acquire like-minded high-quality providers across the United Kingdom. As it grows, the company will continue to build on its operational excellence and care quality with the aim of setting the industry standard for supported living and residential care homes.
Commenting on the transaction, corporate partner Karima Hudson said: "We were delighted to support Intriva Capital on this investment and have no doubt that its backing will enable Sequence to expand and further improve its services to the care sector. We look forward to seeing the business flourish with Intriva's support."
Simon Finn, Managing Partner at Intriva Capital, added: "We are delighted to be investing in one of the most personalised and high-quality care businesses in the country and are passionate about ensuring that Sequence's exceptional care is more widely available to those who need it. We are extremely grateful to the team at Taylor Wessing team who provided invaluable support and insightful guidance throughout the process."
The team was led by partners Karima Hudson and Emma Danks with support from tax partner Liz Wilson and corporate senior associate Suzy Davis. Additional advice was provided by: